There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Singapore is negotiating with the U.S. to ease tariffs on pharmaceuticals and secure access to advanced chips amid shifting ...

Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically ...

Glass House Brands Inc. Q1 2025 Earnings Conference Call May 13, 2025 5:00 PM ET. Company Participants. Kyle Kazan - Co-Founder, Chairman & CEO. Mark Vendetti - CFO. Graham Farrar ...

SAS is making quantum research simple and intuitive for organisations with complex data problems. Quantum computing and related ...

This article focuses on the common regulatory threads that connect different regions and the global standards and principles ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry. Ken Griffin tasted early success while trading during his college days, and it is safe to ...

Apple is reportedly developing brain-computer interface technology to allow users to control devices with thoughts, enhancing ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

Synchron announced that it will become the first brain-computer interface (BCI) maker to achieve native integration with an ...